Recursion Pharmaceuticals, Inc. (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

3.310

+0.020 (0.61%)

At close: Aug 13, 2026, 4:00 PM EDT

3.300

-0.010 (-0.30%)

After-hours: Aug 13, 2026, 7:54 PM EDT

Recursion Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	54.86	74.68	58.84	44.58	39.84	10.18
Revenue Growth	-15.08%	26.92%	32.00%	11.88%	291.46%	156.89%
Cost of Revenue	52.94	70.95	45.24	42.59	48.28	-
Gross Profit	1.91	3.73	13.6	1.99	-8.43	10.18
Selling, General & Admin	151.41	176.59	178.18	110.82	81.6	57.68
Research & Development	394.51	475.27	314.42	241.23	155.7	135.27
Total Operating Expenses	545.92	651.86	492.61	352.05	237.3	192.95
Operating Income	-544.01	-648.13	-479	-350.06	-245.73	-182.78
Total Non-Operating Income (Expense)	20.54	3.24	14.22	17.93	6.25	-3.7
Pretax Income	-523.47	-644.9	-464.79	-332.13	-239.48	-186.48
Provision for Income Taxes	-4.58	-0.14	-1.13	-4.06	-	-
Net Income	-518.88	-644.76	-463.66	-328.07	-239.48	-186.48
Net Income to Common	-518.88	-644.76	-463.66	-328.07	-239.48	-186.48
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	509	447	274	208	176	125
Shares Outstanding (Diluted)	509	447	274	208	176	125
Shares Change	41.48%	63.18%	31.92%	18.41%	40.04%	475.48%
EPS (Basic)	-1.04	-1.44	-1.69	-1.58	-1.36	-1.49
EPS (Diluted)	-1.04	-1.44	-1.69	-1.58	-1.36	-1.49
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-352.27	-378.28	-372.87	-299.74	-120.58	-198.41
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.69	-0.85	-1.36	-1.44	-0.69	-1.58
Gross Margin	3.49%	4.99%	23.12%	4.46%	-21.16%	100.00%
Operating Margin	-991.72%	-867.87%	-814.09%	-785.33%	-616.74%	-1795.79%
Profit Margin	-945.92%	-863.35%	-788.02%	-735.99%	-601.05%	-1832.18%
FCF Margin	-642.18%	-506.52%	-633.71%	-672.43%	-302.64%	-1949.42%
EBITDA	-465.65	-564.43	-442.51	-325.66	-233.97	-174.37
EBITDA Margin	-848.87%	-755.79%	-752.07%	-730.58%	-587.23%	-1713.20%
EBIT	-544.01	-648.13	-479	-350.06	-245.73	-182.78
EBIT Margin	-991.72%	-867.87%	-814.09%	-785.33%	-616.74%	-1795.79%
Effective Tax Rate	0.88%	0.02%	0.24%	1.22%	0.00%	0.00%

SEC Filings: 10-K · 10-Q